Monitoring response to treatment in liver tumours

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 13, Issue 4, 1999, Pages 637-654

  Yang, W T ^a   Johnson, P J ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Hepatocellular carcinoma; Imaging techniques; Response criteria; Tumour markers

Indexed keywords

ALPHA FETOPROTEIN; TUMOR MARKER;

CLINICAL TRIAL; HUMAN; IMAGING; LIVER TUMOR; PATIENT MONITORING; REVIEW; TUMOR NECROSIS; TUMOR VOLUME;

EID: 0033400010     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.1999.0053     Document Type: Article

References (69)

1. Choi B I, Kim T K, Han J K. Power versus conventional colour Doppler sonography: comparison in the depiction of vasculature in liver tumors. Radiology. 200:1996;55-58.
2. Tanaka K, Kitamura T, Fujita M. Color Doppler flow imaging of liver tumors. American Journal of Roentgenology. 154:1990;509-514.
3. Lin Z Y, Wang L Y, Wong J H. Clinical utility of color Doppler sonography in the differentiation of hepatocellular carcinoma from metastases and hemangioma. Journal of Ultrasound in Medicine. 16:1997;51-58.
4. Tano S, Ueno N, Tomiyama T. Possibility of differentiating small hyperechoic liver tumours using contrast-enhanced colour Doppler sonography: a preliminary study. Clinical Radiology. 52:1997;41-45.
5. Ernst H, Hahn E G, Balzer T. Color Doppler ultrasound of liver lesions: signal enhancement after intravenous injection of the ultrasound contrast agent Levovist. Journal of Clinical Ultrasound. 24:1996;31-35.
6. Ohnishi K, Yoshioka H, Kosaka K. Treatment of hypervascular small hepatocelluar carcinoma with ultrasound-guided percutaneous acetic acid injection: comparison with segmental transcatheter arterial embolization. American Journal of Gastroenterology. 91:1996;2574-2579.
7. Sugarbaker P H. Surgical decision making for large bowel cancer metastatic to the liver. Radiology. 174:1990;621-626.
8. Van Leeuwen M S, Noordzij J, Feldberg M A. Focal liver lesions: characterization with triphasic spiral CT. Radiology. 201:1996;327-336.
9. Baron R L, Oliver J H, Dodd G D. Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced helical CT. Radiology. 199:1996;503-511.
10. Van Hoe L, Baert A L, Gryspeerdt S. Dual phase helical CT of the liver. Value of an early-phase acquisition in the differential diagnosis of noncystic focal lesion. American Journal of Roentgenology. 168:1997;1185-1192.
11. Kuszyk B S, Bluemke D A, Urban B A. Portal phase contrast enhanced helical CT for the detection of malignant hepatic tumours: sensitivity based on comparison with intraoperative and pathologic findings. American Journal of Roentgenology. 166:1996;91-95.
12. Yumoto Y, Jinno K, Tokuyama K. Hepatocellular carcinoma detected by iodized oil. Radiology. 154:1985;19-24.
13. Okayasu I, Hatakeyama S, Yoshida T. Selective and persistent deposition and gradual drainage of iodized oil, lipiodol in hepatocellular carcinoma after injection into the feeding hepatic artery. Cancer. 90:1988;536-544.
14. Ngan H. Lipiodol computerized tomography: how sensitive and specific is the technique in the diagnosis of hepatocellular carcinoma? British Journal of Radiology. 63:1990;771-775.
15. Bluemke D A, Fishman E K. Spiral CT arterial portography of the liver. Radiology. 186:1993;576-579.
16. Lupetin A R, Cammisa B A, Beckman I. Spiral CT during arterial portography. Radiographics. 16:1996;723-743.
17. Whitney W S, Herfkens R J, Jeffrey R B. Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1·5T. Radiology. 189:1993;863-870.
18. Itai Y, Ohnishi S, Ohtomo K. Regenerating nodules of liver cirrhosis: MR imaging. Radiology. 165:1987;419-423.
19. Karani J, Williams R. Review: The staging of hepatocellular carcinoma. Clinical Radiology. 47:1993;297-301.
20. Lau W Y, Leung T WT, Ho S. Diagnostic pharmaco-scintigraphy with hepatic intra-arterial technetium-99m macroaggregated albumin in the determination of tumour to non-tumour uptake ratio in hepatocellular carcinoma. British Journal of Radiology. 67:1994;136-139.
21. Leung T WT, Lau W Y, Ho S. Determination of tumour vascularity using selective hepatic angiography as compared with intrahepatic-arterial technetium-99m macroaggregated albumin scan in hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology. 33:1994;S33-S36.
22. Findlay M, Young H, Cunningham D. Noninvasive monitoring of tumour metabolism using fluoro-deoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumour response to fluorouracil. Journal of Clinical Oncology. 14:1996;700-708.
23. Chayvialle J AP, Ganguli P C. Radioimmunoassay of alpha-fetoprotein in human plasma. Lancet. 1:1973;1355-1357.
24. Hirai H, Nishi S, Watabe H. Radioimmunoassay of alpha-fetoprotein. Protides of the Biological Fluids. 1972;Pergamon Press. p. 579-587.
25. Heyward W L, Lanier A P, Bener T R. Early detection of primary hepatocellular carcinoma by screening for alpha-fetoprotein in high-risk families. Lancet. ii:1983;1161-1162.
26. McIntire K R, Waldmann T A, Moertal C G, Go V LW. Serum alpha feto-protein in patients with neoplasms of the gastrointestinal tract. Cancer Research. 35:1975;991-996.
27. Bernades P, Smadja M, Rueff B. Presence de l'alpha-foetoproteine serique dans quatre cas de cancers. Digestifs autres que l'hepatome. Presse Medicale. 79:1971;1585-1587.
28. Bloomer J R, Waldmann T A, McIntire K R, Klatskin G. Serum alpha feto-protein levels in patients with non-neoplastic liver diseases. Gastroenterology. 65:1973;530.
29. Johnson P J, Portmann B, Williams R. Alpha-fetoprotein concentration measured by radioimmunoassay in the diagnosing and excluding of hepatocellular carcinoma. British Medical Journal. 2:1978;661-663.
30. Shiraki K, Takase K, Tameda T. A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients. Hepatology. 22:1995;802-807.
31. Sato Y, Nakata K, Kato Y. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. New England Journal of Medicine. 328:1993;1802-1806.
32. Burditt L, Johnson M, Johnson P J, Williams R. Detection of hepatocellular carcinoma-specific alpha-fetoprotein by isoelectric focusing. Cancer. 74:1994;25-29.
33. Ho S, Cheng P, Johnson P J. Isoelectric focusing of alphafetoprotein in patients with hepatocellular carcinoma: frequency of specific banding patterns at non-diagnostic levels. British Journal of Cancer. 73:1996;985-989.
34. Johnson P J, Leung N, Cheng P. 'Hepatoma-specific' alphafetoprotein may permit preclinical diagnosis of malignant change in patients with chronic liver disease. British Journal of Cancer. 75:1997;236-240.
35. Melia W M, Bullock S, Johnson P J. Serum ferritin in hepatocellular carcinoma, comparison with alphafetoprotein. Cancer. 51:1983;2112-2115.
36. Sawabu N, Nakagen M, Ozaki K. Clinical evaluation of specific y-GTP isoenzyme in patients with hepatocellular carcinoma. Cancer. 51:1983;327-331.
37. Szuki H, Iino S, Endo Y. Tumor-specific alkaline phosphatase in hepatoma. Annals of the New York Academy of Science. 259:1975;3307-3316.
38. Shimada M, Takenaka K, Fujiwara Y. Des-γ-carboxy prothrombin and alpha-fetoprotein status as a new prognostic indicator after hepatic resection for hepatocellular carcinoma. Cancer. 78:1996;2094-2100.
39. 12binding protein a tumour marker for hepatocellular carcinoma. Journal of the Gut. 19:1978;1105-1109.
40. Collier N A, Weinbren K, Bloom S R. Neurotensin secretion by fibrolamellar carcinoma of the liver. Lancet. i:1984;538-540.
41. Letourneau J G, Steely J W, Crass J R. Upper abdomen: CT findings following partial hepatectomy. Radiology. 166:1988;139-141.
42. Johnson P J, Williams R. Serum alpha-fetoprotein estimations and doubling time in hepatocellular carcinoma: influence of therapy and possible value in early detection. Journal of the National Cancer Institute. 64:1980;1329-1332.
43. Urabe T S, Hayashi S, Terasaki M. An assessment of therapeutic effect of hepatocellular carcinoma by the serial change of serum AFP value. Japanese Journal of Gastroenterology. 87:1990;100-108.
44. Johnson P J, Williams R, Thomas H. Induction of remission in hepatocellular carcinoma with doxorubicin. Lancet. i:1978;1006-1009.
45. Leung T WT, Patt YZ, Lau W-Y. Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma. Clinical Cancer Research. 5:1999;1676-1681.
46. Dong B, Liang P, Yu X. Sonographically guided microwave coagulation treatment of liver cancer: an experimental and clinical study. American Journal of Roentgenology. 171:1998;449-454.
47. Rossi S, Stasi M D, Buscarini E. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. American Journal of Roentgenology. 167:1996;759-768.
48. Amin Z, Donald J, Masters A. Hepatic metastases: interstitial laser photocoagulation with real-time US monitoring and dynamic CT evaluation of treatment. Radiology. 187:1993;339-347.
49. Shiina S, Tagawa K, Niwa Y. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. American Journal of Roentgenology. 160:1993;1023-1028.
50. Ebara M, Kita K, Sugiura N. Therapeutic effect of percutaneous ethanol injection on small hepatocellular carcinoma: evaluation with CT. Radiology. 195:1995;371-377.
51. Shiina S, Tagawa K, Unuma T. Percutaneous ethanol injection therapy for hepatocellular carcinoma: a histopathologic study. Cancer. 68:1991;1524-1530.
52. Lencioni R, Caramella D, Bartolozzi C. Hepatocellular carcinoma: use of color Doppler US to evaluate response to treatment with percutaneous ethanol injection. Radiology. 194:1995;113-118.
53. Joseph F B, Baumgarten D A, Bernardino M E. Hepatocellular carcinoma: CT appearance after percutaneous ethanol ablation therapy. Radiology. 186:1993;553-556.
54. Seki T, Wakabayashi M, Nakagawa T. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer. 74:1994;817-825.
55. Rossi S, Fornari F, Paties C, Buscarini L. Thermal lesions induced by 480 kHz localized current field guinea pig and in pig liver. Tumori. 76:1990;54-55.
56. Bartolozzi C, Lencioni R, Caramella D. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging. American Journal of Roentgenology. 162:1994;827-831.
57. Sironi S, De Cobelli F, Livraghi T. Small hepatocellular carcinoma treated with percutaneous ethanol injection: unenhanced and gadolinium-enhanced MR imaging follow-up. Radiology. 192:1994;407-412.
58. Sironi S, Livraghi T, Angeli E. Small hepatocellular carcinoma: MR follow-up of treatment with percutaneous ethanol injection. Radiology. 187:1993;119-123.
59. Takayasu K, Moriyama N, Muramatsu Y. The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients. American Journal of Roentgenology. 155:1990;49-54.
60. Ravikumar T S, Kane R, Cady B. A 5-year study of cryosurgery in the treatment of liver tumors. Archives of Surgery. 126:1991;1520-1524.
61. Onik G M, Rubinsky B, Zemel R. Ultrasound-guided cryosurgery in the treatment of metastatic colon cancer. Cancer. 67:1991;901-907.
62. Kuszyk B S, Choti M A, Urban B A. Hepatic tumors treated by cryosurgery: normal CT appearance. American Journal of Roentgenology. 166:1996;363-367.
63. McLoughlin R F, Saliken J F, McKinnon G. CT of the liver after cryotherapy of hepatic metastases: imaging findings. American Journal of Roentgenology. 165:1995;329-332.
64. Tanaka K, Inoue S, Numata K. Color Doppler sonography of hepatocellular carcinoma before and after treatment by transcatheter arterial embolization. American Journal of Roentgenology. 158:1992;541-546.
65. Leung W T, Lau W Y, Ho S. Selective internal radiation therapy with intraarterial iodine-131-lipiodol in inoperable hepatocellular carcinoma. Journal of Nuclear Medicine. 35:1994;1313-1318.
66. 90Yttrium microspheres. International Journal of Radiation Oncology, Biology and Physics. 40:1998;583-592.
67. Breiman R S, Beck J W, Korobkin M. Volume determinations using computed tomography. American Journal of Roentgenology. 138:1982;329-333.
68. Jeffrey R B Jr, Moss A A, Quivey J M. CT of radiation-induced hepatic injury. American Journal of Roentgenology. 135:1980;445-448.
69. Berland L L, Lee J KT. Liver and biliary tract. Lee J KT, Sagel S S, Stanley R J. Computed Body Tomography with MRI Correlation. 1989;593-660 Raven Press, New York.